AngioDynamics (ANGO) Tops Q2 EPS by 2c; Boosts Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
AngioDynamics (ANGO) PT Raised to $21 at Piper Jaffray Amid Strong Q2
January 9, 2015 7:55 AM ESTPiper Jaffray analyst Thomas Gunderson reiterated an Overweight rating and boosted estimate and his price target on AngioDynamics (NASDAQ: ANGO) to $21.00 (from $17.00) following strong Q2 numbers.
Gunderson commented, "ANGO delivered a strong Q2 (Nov) relative to expectations with revenues of $92.1M (up 5%) and... More
